A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | R | S | T | V | W | Y | Z

Enter our

Follow HFN


Dec 08, 2013

HFN advises Merck Serono Ventures in Two Investments

HFN advised Merck Serono Ventures (MS Ventures), the corporate venture capital arm of Merck Serono (the biopharmaceutical division of Merck KGaA) in two investments.

In the first investment HFN advised a syndicate of investors led by MS Ventures, Boehringer Ingelheim Venture Fund, and Pontifax Fund, with the participation of the Technion Research and Development Fund, in a seed financing round in MetaboMed Ltd, a newly created biotech company in the field of cancer metabolism founded by three leading researchers in the field of cancer metabolism and computational biology.

In the second investment HFN advised MS Ventures in an agreement for seed financing in ChanBio Ltd., an Israeli startup founded by Dr. Oren Bogin

Both MetaboMed and ChanBio joined the Merck Serono Israel Bioincubator. The € 10 million MS Ventures Israel Bioincubator Fund is focused on pre-seed and seed opportunities originating in Israel.

These matters were handled by Hi-Tech department co-head Maya Racine-Netser and by Dan Sharot